Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Ain NU; Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 25100, Khyber Pakhtunkhwa, Pakistan.; Institute of Pharmaceutical Sciences, Khyber Medical University, Peshawar 25100, Khyber Pakhtunkhwa, Pakistan.
Subjects: Rivaroxaban*/Rivaroxaban*/Rivaroxaban*/therapeutic use ; Rivaroxaban*/Rivaroxaban*/Rivaroxaban*/pharmacokinetics ; Rivaroxaban*/Rivaroxaban*/Rivaroxaban*/adverse effects
-
Source:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Oct 18; Vol. 60 (10). Date of Electronic Publication: 2024 Oct 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet
Record details
-
Authors :
Klimoszek D; Faculty of Pharmaceutical Sciences in Sosnowiec, Doctoral School, Medical University of Silesia in Katowice, 40-007 Katowice, Poland.; Jeleń M
Subjects: Algorithms* ; Cytochrome P-450 CYP3A*; Humans
-
Source:
Molecules (Basel, Switzerland) [Molecules] 2024 Apr 08; Vol. 29 (7). Date of Electronic Publication: 2024 Apr 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:
Record details